Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
Year: 2017
Type: erratum
Abstract: After the publication of the article [[1][1]], the treatment algorithm for advanced/metastatic bladder cancer in Fig. [3][2] was updated to reflect the current use of immunotherapy in this setting. The correct Fig. [3][2] can be seen here and the original article has been updated to reflect this
Authors: Ashish M. Kamat, Joaquim Bellmunt, Matthew D. Galsky, Badrinath R. Konety, Donald L. Lamm, David Langham, Cheryl T. Lee, Matthew I. Milowsky, Michael A. O’Donnell, Peter H. O’Donnell, Daniel P. Petrylak, Padmanee Sharma, Eila C. Skinner, Guru Sonpavde, John A. Taylor, Prasanth Abraham, Jonathan E. Rosenberg
Institutions: The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, Mount Sinai Medical Center, Tisch Cancer Institute, University of Minnesota, Bladder Cancer Advocacy Network, The Ohio State University Wexner Medical Center, University of North Carolina at Chapel Hill, University of Iowa, University of Chicago, Yale Cancer Center, Stanford University, University of Alabama, University of Alabama at Birmingham, University of Kansas, The University of Kansas Cancer Center, Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2765486512